Linkage between patients’ characteristics and prescribed systemic treatments for psoriasis: A semantic connectivity map analysis of the Swiss Dermatology Network for Targeted Therapies registry
Journal of the European Academy of Dermatology and Venereology | Nov 07, 2019
Cross-reactivity in beta-lactams after a non-immediate cutaneous adverse reaction: Experience of a reference centre for toxic bullous diseases and severe cutaneous adverse reactions
Journal of the European Academy of Dermatology and Venereology | Nov 07, 2019
Advanced cutaneous squamous cell carcinoma: Real world data of patient profiles and treatment patterns
Journal of the European Academy of Dermatology and Venereology | Nov 07, 2019
Secukinumab is effective in treatment of moderate-to-severe plaque psoriasis: Real-life effectiveness and safety from the PROSPECT study
Journal of the European Academy of Dermatology and Venereology | Nov 01, 2019
Quality of life outcomes in adults with moderate-to-severe plaque psoriasis treated with dimethylfumarate (DMF): A post hoc analysis of the BRIDGE study
Journal of the European Academy of Dermatology and Venereology | Nov 01, 2019
Prospective randomized controlled trial comparing treatment efficacy and tolerance of picosecond alexandrite laser with a diffractive lens array and triple combination cream in female Asian patients with melasma
Journal of the European Academy of Dermatology and Venereology | Nov 01, 2019
Weekly adalimumab treatment decreased disease flare in hidradenitis suppurativa over 36 weeks: Integrated results from the phase 3 PIONEER trials
Journal of the European Academy of Dermatology and Venereology | Oct 31, 2019
Treatment of rosacea and demodicosis with benzyl benzoate: Effects of different doses on Demodex density and clinical symptoms
Journal of the European Academy of Dermatology and Venereology | Oct 28, 2019